Cholinesterase Inhibitory Activity and Molecular Docking Studies of Isocryptolepine‐Triazole Adducts
ChemMedChem · 2024
DOI: 10.1002/cmdc.202400447 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, 2024. Verfasst von Jumreang Tummatorn und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Medicinal Chemistry, Chulabhorn Research Institute, Center of Excellence on Environmental Health and Toxicology (EHT), OPS, MHESI, Bang…. Hauptthemen laut MEDLINE: Cholinesterase Inhibitors, Acetylcholinesterase, Molecular Docking Simulation, Triazoles. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: Postdoctoral Research Fund from Chulabhorn Graduate Institute, Thailand Science Research and Innovation (TSRI), Chulabhorn Research Institute.
Abstract (Originalsprache)
Due to the rising prevalence of Alzheimer's disease (AD), there is a pressing need for more effective drugs to treat or manage AD's symptoms. Studies have shown that cholinesterase inhibition can improve cognitive and behavioral symptoms associated with AD, by addressing the cholinergic deficit. Based on the recent development of cholinesterase inhibitors with indoloquinoline and triazole moiety, we rationalized that compounds with an isocryptolepine‐triazole scaffold may also have the same biological targets. In this study, eighteen previously synthesized isocryptolepine‐triazole compounds were assessed for their ability to inhibit acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). The majority of these compounds demonstrated potent selective AChE inhibition. Furthermore, our molecular docking and molecular dynamic simulation studies reveal that the isocryptolepine and triazole moieties are important for the binding of the compounds with the periphery of the AChE's binding pocket. While reductions in molecular weights and lipophilicities may be necessary to improve their pharmacokinetic properties, this work provides valuable insights for designing future AChE inhibitors, based on the novel isocryptolepine‐triazole scaffold.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Medicinal Chemistry, Chulabhorn Research Institute, Center of Excellence on Environmental Health and Toxicology (EHT), OPS, MHESI, Bangkok, 10400, Thailand.
- Program in Chemical Sciences, Chulabhorn Graduate Institute, Bangkok, 10210, Thailand.
- Center for Advanced Therapeutics (CAT), Institute of Molecular Biosciences, Mahidol University, Nakhon Pathom, 73170, Thailand.
- Laboratory of Organic Synthesis, Chulabhorn Research Institute, Bangkok, 10210, Thailand.
- Laboratory of Natural Products, Chulabhorn Research Institute, Bangkok, 10210, Thailand.
- Hebei Key Laboratory of Applied Chemistry, Hebei Key Laboratory of Nano-biotechnology, Yanshan University, Qinhuangdao, 066004, China.
ORCID-Profile: Jumreang Tummatorn
Förderung
- Postdoctoral Research Fund from Chulabhorn Graduate Institute
- Thailand Science Research and Innovation (TSRI)
- Chulabhorn Research Institute
- National Research Council of Thailand (NRCT)
- Chulabhorn Graduate Institute
- Chulabhorn Research Institute, Mahidol University, and the Center of Excellence on Environmental Health and Toxicology (EHT), OPS, MHESI, Ministry of Education
- Ministry of Higher Education, Science, Research and Innovation, Thailand
- Chulabhorn Graduate Institute, Chulabhorn Royal Academy
Zitieren
APA
Tummatorn, J., Meewan, I., Khunnawutmanotham, N., Chimnoi, N., Suwanwong, N., Rodphon, W., Thongsornkleeb, C., Yang, J., & Ruchirawat, S. (2024). Cholinesterase Inhibitory Activity and Molecular Docking Studies of Isocryptolepine‐Triazole Adducts. ChemMedChem. https://doi.org/10.1002/cmdc.202400447
Vancouver
Tummatorn J, Meewan I, Khunnawutmanotham N, Chimnoi N, Suwanwong N, Rodphon W, et al. Cholinesterase Inhibitory Activity and Molecular Docking Studies of Isocryptolepine‐Triazole Adducts. ChemMedChem. 2024. doi:10.1002/cmdc.202400447
BibTeX
@article{Tummatorn2024,
author = {Tummatorn, Jumreang and Meewan, Ittipat and Khunnawutmanotham, Nisachon and Chimnoi, Nitirat and Suwanwong, Nutchapong and Rodphon, Warabhorn and Thongsornkleeb, Charnsak and Yang, Jingyue and Ruchirawat, Somsak},
title = {Cholinesterase Inhibitory Activity and Molecular Docking Studies of Isocryptolepine‐Triazole Adducts},
journal = {ChemMedChem},
year = {2024},
doi = {10.1002/cmdc.202400447}
}
EUVIMED